9th Cancer Pain Meeting

UNDER DEVELOPMENT

Cancer pain affects millions of Americans. There are over 17 million cancer survivors in the US as a result of remarkable advances in cancer diagnosis and therapy. This number will rise >30%, to 22.2 million by 2030*. 

An estimated 40% of cancer survivors continue to experience persistent pain as a result of treatments such as surgery, chemotherapy, and radiation therapy.

How will we help them?

Patients with persistent pain associated with cancer and/or cancer treatment often receive less optimal care with restricted treatment modalities.

This workshop will emphasize multimodal and multidisciplinary treatment as part of cancer-related pain management and palliative care.

*2019, National Cancer Institute, Division of Cancer Control & Population Sciences +Van Den Beuken-Van, M. H., Hochstenbach, L. M., Joosten, E. A., Tjan- Heijnen, V. C., & Janssen, D. J. (2016). Update on prevalence of pain in patients with cancer: systematic review and metaanalysis. Journal of pain and symptom management, 51(6), 1070-1090.

Speaker(s):

• Dr. David J. Copenhaver, MD, Division Chief, Pain Medicine, UC Davis Health
• Dr. Sanjeet Narang, MD, Director, Oncology Pain Management, Brigham and Women's Hospital
• Dr. Amy A. Case, MD, FAAHPM, Lee Foundation Endowed Chair of the Department of Palliative and Supportive Care; Palliative Care Program Chief, Roswell Park Comprehensive Cancer Center
• Dr. David Hui, MD, Tenured Associate Professor of Palliative, Rehabilitation, and Integrative Medicine, MD Anderson Cancer Center
• Dr. Hemant Kalia, MD, Program Director, Interventional Spine & Pain Fellowship Program, Rochester Regional Health
• Dr. Jill E. Sindt, MD, Associate Director of Pain Medicine, Huntsman Cancer Hospital, Supportive Oncology & Survivorship Service

Click Here to Register